No abstract available.
Ear, Middle*

No abstract available.

No abstract available.

No abstract available.

No abstract available.

No abstract available.
Ear, Middle* ; Eustachian Tube*

Adult-onset egg allergy is rare compared to child-onset egg allergy, and the component-resolved diagnosis test is effective in evaluating food allergy. We herein report a 24-year-old woman with late-onset egg-yolk allergy diagnosed as bird-egg syndrome. The prolonged exposure to pet parrots' dander or dropping through the respiratory system caused sensitization to the Gal d 5 component and resulted in a cross-reaction to egg yolk. Since the patient was suspected of the syndrome by her history, the skin prick test, ISAC ImmunoCAP, and serum ImmunoCAP test were performed. By confirming Gal d 5 component by ISAC ImmunoCAP, the patient was diagnosed with the syndrome. In patients with newly adult-onset food allergy, the clinician must identify the environmental conditions which can cause cross-sensitization and perform the causative component test.

To evaluate the efficacy of oplyhexamethylene biguanide(PHMB) in Staphylococcus aureus (S. aureus) keratitis model, 10microliter of S. sureus bacterial suspension(1x10(5) colony-forming unit(cfu)/ml) were infected intrastromally into rabbit corneas. 18 rabbits were divided into three treatment groups : balanced salt solution (BSS) group(n=18 eyes), PHMB(0.02%, 200microgram/ml) group(n=9), cefazolin(40 microgram/ml) group(n=9). Topical antibiotic drops were given hourly starting at 24 hours after inoculation. A subconjunctival injection was given every 24 hours for the study duration(96 hours). The severity of keratitis was scored in masked fashion every 12 hours. Corneal buttons were excised and homogenized at the end of the study to determine viable bacterial counts. In the S. aureus keratitis model, there was no difference of clinical scores between BSS, cefazolin, PHMB group at 72 hours, and the number of viable bacteria recovered from the corneal button in log(10) cfu was 2.65+/-1.85, 3.30+/-0.85, 2.86+/-1.36, in BSS, cefazolin, PHMB group respectively. No differences in either clinical scores or bacterial counts were found between the PHMB and BSS groups. PHMB appears to be ineffective against S. aureus in this model of experimental keratitis.
Bacteria ; Bacterial Load ; Cefazolin ; Cornea ; Keratitis* ; Masks ; Rabbits ; Staphylococcus aureus* ; Staphylococcus*

During angiogenesis, binding of urokinase plasminogen activator(uPA) and its receptor(uPAR) has been implicated as an important component of the angiogenesis pathway. We have produced a high-affinity competitive antagonist for the uPA receptor consisting of a fusion protein linking the endothelial growth factor(EGF)-like domain of uPA(residues 1-48) to the Fc domain of IgG. To determine whether this recombinant murine uPA1-48-IgG fusion protein could interfere with angiogenesis, we studied the effect of this compound on rat corneal angiogenesisinduced by basic fibroblast growth factor(bFGF). A hydrogel disk containing 250ng of bFGF and 4.2ug of uPA1-48-IgG fusiong protein in seven eyes, 250ug of bFGF and 4.2ug of phosphate-buffered saline(PBS) in another sseven eyes were implanted intrastromally 1.5mm from the superior limbus. At five days post-implantation of bFGF disk, the eyes treated with uPA1-48IgG fusion protein had reduced angiogenesis (mean score=3.1) compared with the PBS-treated controls(mean score=6.1)(P<0.05, Wilcoxon rank sum test). In a rat corneal pocket assay, murine uPA1-48-IgG fusion protein appears to inhibit bFGF-induced angiogenesis. Compounds that block uPAR binding of uPA may have therapeutic potential as anti-angiogenic agents.
Animals ; Corneal Neovascularization* ; Fibroblast Growth Factor 2* ; Fibroblasts ; Hydrogel ; Immunoglobulin G ; Plasminogen Activators* ; Plasminogen* ; Rats* ; Urokinase-Type Plasminogen Activator*

To evaluate the efficacy of polygexamethylene biguanide(PHMB) in Pseudomonas aeruginosa(P. aeruginosa) keratites model, 10microliter of P. aeruginosa bacterial suspension(1x103 colony-forming unit(cfu)/ml) was injected intrastromally into rabbit corneas. Eighteen rabbits(36 eyes) were divided into three treatment groups: balanced salt solution(BSS) group(N=18 eyes). PHMB(0.02%, 200microliter/ml) group(n=9 eyes), tobramycin(14microliter/ml) group(n=9 eyes). Topical antibiotic drops were given hourly from 12 hours after inoculation. A subconjunctival infection was every 24 hours during the first 72 hours. The Severity of keratitis was scored in basked fashion every 8 hours. Corneal buttons were excised and homogenized at the end of the study to determine the viable bacterial counts. In P. aeruginosa keratitis model, tobramycin was statistically more efficacious than PHMB, according the clinical scores at 58 hours(9.9 vs. 15.1, P<0.0001) and log10 cfu(0.54+/-0.21 vs. 4.87+/-1.07. P<0.0001). No differences were found between the PHMB and BSS groups in either clinical scores or bacterial counts. PHMB appears to be ineffective against P. aeruginosa in experimental keratitis model of rabbit.
Bacterial Load ; Cornea ; Keratitis* ; Pseudomonas aeruginosa* ; Pseudomonas* ; Tobramycin